2-acylaminopropanamides as tachykinin receptor antagonists
申请人:Eli Lilly and Company
公开号:US05565568A1
公开(公告)日:1996-10-15
This invention provides a series of novel substituted propanamides which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.